August edition of Australian Prescriber out now

Who profits from fast-track drug approvals: patients or industry?
Paul Kubler, from Royal Brisbane and Women’s Hospital, offers a balanced analysis of the benefits and potential dangers of allowing early access to new therapies. 

Colic: which treatments work and which don’t?
Valerie Sung, a paediatrician at the Royal Children’s Hospital in Melbourne and research fellow at the Murdoch Children’s Research Institute, discusses the latest thinking on colic. Is it always related to intestinal issues and how can it be managed? 

Combining anticoagulants and antiplatelet drugs in coronary artery disease
Health professionals may consider combining anticoagulation and antiplatelet drugs in patients with coronary artery disease, to prevent further cardiovascular events. This article details approaches for patients with stable coronary disease or acute coronary syndrome.

Other articles in the August issue of AustralianPrescriber include:

ENDS

 

Media contact

Jon Abbott
02 8217 9625, 0419 618 365 or [email protected]

Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals. It is published by NPS MedicineWise, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health. Australian Prescriber is published every two months and is available online at nps.org.au/australianprescriber